Vis enkel innførsel

dc.contributor.authorFrøyland, Livar
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorHolvik, Kristin
dc.contributor.authorLøvik, Martinus
dc.contributor.authorStrand, Tor A
dc.contributor.authorTell, Grethe S.
dc.contributor.authorVaktskjold, Arild
dc.contributor.authorIversen, Per Ole
dc.coverage.spatialNorwaynb_NO
dc.date.accessioned2018-04-27T12:32:24Z
dc.date.available2018-04-27T12:32:24Z
dc.date.created2017-10-19T10:42:26Z
dc.date.issued2015
dc.identifier.isbn978-82-8259-182-9
dc.identifier.urihttp://hdl.handle.net/11250/2496402
dc.description.abstractThe Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) in food supplements. VKM concludes that: • The specified doses of 1500, 1750 or 1825 mg/day of EPA in food supplements are unlikely to cause adverse health effects in adults (≥18 years). Due to few studies in children and adolescents, no conclusion can be drawn for these groups for EPA. • The specified doses of 1050 and 1290 mg/day of DHA in food supplements are unlikely to cause adverse health effects in the general population including children (≥10 years), adolescents and adults (≥18 years). • No dosage of DPA in food supplements can be evaluated due to lack of data. It is emphasised that this risk assessment concerns the single fatty acids EPA, DPA or DHA separately and not mixtures of these as found in e.g. fish oil and cod liver oil.nb_NO
dc.language.isoengnb_NO
dc.publisherNorwegian Committee for Food Safety (VKM)nb_NO
dc.relation.ispartofVKM Report
dc.relation.ispartofseriesVKM Report;
dc.relation.urihttps://vkm.no/download/18.645b840415d03a2fe8f26067/1502708618203/3ef862160c.pdf
dc.rightsNavngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/deed.no*
dc.subjectAdverse health effectnb_NO
dc.subjectDHAnb_NO
dc.subjectdocosahexaenoic acidnb_NO
dc.subjectdocosapentaenoic acidnb_NO
dc.subjectDPAnb_NO
dc.subjecteicosapentaenoic acidnb_NO
dc.subjectEPAnb_NO
dc.subjectfood supplementnb_NO
dc.subjectn-3 LCPUFAnb_NO
dc.subjectnegative health effectnb_NO
dc.subjectNorwegian Scientific Committee for Food Safetynb_NO
dc.subjectomega-3nb_NO
dc.subjectother substancesnb_NO
dc.subjectrisk assessmentnb_NO
dc.subjectVKMnb_NO
dc.titleRisk assessment of “other substances” – eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safetynb_NO
dc.typeResearch reportnb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber65nb_NO
dc.source.issue27nb_NO
dc.identifier.cristin1505821
cristin.unitcode1991,0,0,0
cristin.unitnameSykehuset Innlandet HF
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal